Current Diagnosis and Treatment of Central Nervous System Germ Cell Tumours

Overview

Journal Curr Opin Neurol

Specialty Neurology

Date 1996 Dec 1

PMID 9007398

Citations 8

Authors

Y Sawamura

Affiliations

Soon will be listed here.

Abstract

Central nervous system germ cell tumours can be cured with high quality posttreatment neuropsychological and endocrinological measures. In order to firmly establish a histological diagnosis, surgery is essential. Management should be planned precisely according to histological and biological malignancy and the extent of the disease. Patients with germinoma can be cured by preirradiation chemotherapy followed by reduced dose irradiation.

Citing Articles

A rare giant mixed germ cell tumor of the pineal region with immature elements: Case report and review of the literature.

Milton C, Pelargos P, Stetson N, Maldonado-Vital M, Fung K, Dunn I Rare Tumors. 2021; 13:20363613211026501.

PMID: 34221291 PMC: 8221666. DOI: 10.1177/20363613211026501.

Predictors of long-term survival following postoperative radiochemotherapy for pathologically confirmed suprasellar germ cell tumors.

Huo L, Wang X, Allen P, Wang L, Liao Y, Han Z Mol Clin Oncol. 2015; 3(2):430-434.

PMID: 25798281 PMC: 4360867. DOI: 10.3892/mco.2014.461.

Diabetes insipidus in pediatric germinomas of the suprasellar region: characteristic features and significance of the pituitary bright spot.

Kilday J, Laughlin S, Urbach S, Bouffet E, Bartels U J Neurooncol. 2014; 121(1):167-75.

PMID: 25266413 DOI: 10.1007/s11060-014-1619-7.

The clinical characteristics and treatment outcome of 57 children and adolescents with primary central nervous system germ cell tumors.

Sun X, Zhang F, Zhen Z, Yang Q, Xia Y, Wu S Chin J Cancer. 2014; 33(8):395-401.

PMID: 25011460 PMC: 4135369. DOI: 10.5732/cjc.013.10112.

Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy.

Afzal S, Wherrett D, Bartels U, Tabori U, Huang A, Stephens D J Neurooncol. 2009; 97(3):393-9.

PMID: 19820898 DOI: 10.1007/s11060-009-0033-z.